Cue Biopharma
Clinical trials sponsored by Cue Biopharma, explained in plain language.
-
New drug targets Hard-to-Treat cancers in early trial
Disease control CompletedThis early-stage study tested a new drug called CUE-102 in 42 adults with certain advanced cancers (colorectal, stomach, pancreatic, or ovarian) that had returned or spread and were no longer responding to standard treatments. The goal was to find a safe dose and see if the drug …
Phase: PHASE1 • Sponsor: Cue Biopharma • Aim: Disease control
Last updated May 17, 2026 11:37 UTC
-
New drug combo shows promise against HPV head and neck cancer
Disease control CompletedThis early-stage study tested a new drug called CUE-101, alone or with another drug (pembrolizumab), in 80 people with a type of head and neck cancer linked to HPV. The main goals were to check safety and find the right dose. Researchers also looked at whether the tumors shrank. …
Phase: PHASE1 • Sponsor: Cue Biopharma • Aim: Disease control
Last updated May 17, 2026 11:34 UTC